Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylphenidate Treatment of Attentional and Cognitive Deficits in Epilepsy

NCT02178995 is registered in ClinicalTrials.gov with Kimford Jay Meador as lead sponsor.

NCT NCT02178995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02178995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylphenidate Treatment of Attentional and Cognitive Deficits in Epilepsy
Lead sponsor
Kimford Jay Meador
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2014
Completion date
December 31, 2015
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficits, cognitive deficits, epilepsy